Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams rich in diversity. Take your career farther than you thought possible.
Responsibilities:
The Manager, Access & Value Strategy is part of the Disease Area Access Team and supports all HTA (Health Technology Assessment) related topics along a product’s life cycle.
In alignment with the Associate Director, Market Access / Senior Manager, Access & Value Strategy, the Manager, Access & Value Strategy contributes to the early benefit assessment (AMNOG) of our products:
1. He / she interacts with the relevant global teams explaining the local health care system. In alignment with the Associate Director and/or Senior Manager, he/she supports advice submissions to the Federal Joint Committee (G-BA) regarding the framework for benefit assessment, e.g., on appropriate comparator and clinical endpoints.
2. In alignment with the Associate Director, Market Access / Senior Manager, Access & Value Strategy, he/she supports the timely submission of the complete value dossier to the G-BA, seeking cross-functional support from German Biostats, Medical, Regulatory, and the Business Unit.
3. He / she supports all steps during the value assessments like assessment analysis, written statements, and oral hearing including evidence collection & evaluation as well as KOL/expert support.
4. He / she supports the Associate Director, Market Access / Senior Manager, Access & Value Strategy with reviews and scientific literature evaluations continuously and monitors relevant competitors’ AMNOG processes including continuous reporting on the key outcomes and lessons learned.
The Manager, Access & Value Strategy:
1. is part of the cross-functional, indication specific (launch) team, led by the BU.
2. supports the pricing team with AMNOG price negotiation (and potential arbitration board) by HTA, epidemiological, and indication excellence.
3. works closely with the Manager Access & Payer Strategy to ensure seamless communication to key FAM/KAM stakeholders on HTA related questions.
4. works closely with the RWE Manager to ensure evidence generation according to AMNOG needs.
Requirements:
1. The Manager, Access & Value Strategy needs the willingness to work within interdisciplinary matrix teams under time pressure.
2. The Manager, Access & Value Strategy has a university degree in life science and/or economics and is trained in health economics and/or has experience in the pharmaceutical industry in various positions (market access, HEOR, pricing).
3. He / she has knowledge of the entire German Market Access process (AMNOG), the German health care and drug legislation, as well as knowledge of German Market Access requirements for the Pharmaceutical industry.
4. Knowledge in study design and study data interpretation (basics in statistics), in evidence-based medicine methodology (IQWIG methodology), and HEOR methods is appreciated.
5. The Manager, Access & Value Strategy should be a team player and enjoy working across functions.
6. Analytical and strategic problem-solving skills are of crucial value.
7. The Manager, Access & Value Strategy needs advanced writing and communication skills.
8. Basic MS-Office capabilities are crucial. Further, knowledge in bibliographic management software (e.g., reference manager) and statistical software applications are appreciated.
9. Fluent in English oral and written is mandatory.
This position is fixed term (until 31.12.2025).
#J-18808-Ljbffr